Waqar Haque

Dr. Waqar Haque


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 April 2018 in Breast Cancer Research and Treatment
Verified
Journal Article
Closed access
PDF file
WHWaqar M. Haque
Waqar M. Haque
VVVivek Verma
Vivek Verma
SHSandra Hatch
Sandra Hatch
VKV. Suzanne Klimberg
V. Suzanne Klimberg
EBE. Brian Butler
E. Brian Butler
BTBin S. Teh
Bin S. Teh

1 February 2020 in The Breast
Verified
Journal Article
Open access
PPPraveen Polamraju
Praveen Polamraju
WHWaqar M. Haque
Waqar M. Haque
KCKevin Cao
Kevin Cao
VVVivek Verma
Vivek Verma
MSMary Schwartz
Mary Schwartz
BTBin S. Teh
Bin S. Teh
Metaplastic breast cancer (MBC) is a rare, aggressive variant of breast cancer that has been associated with poor clinical outcomes, as has triple-negative breast (TNBC) cancer. Limited studies compare the clinical characteristics and prognosis of MBC to TNBC. This study uses a large, contemporary US cancer database to compare clinical characteristics and survival outcomes for patients with MBC to those with TNBC. The National Cancer Database was queried for women with cT1-4N1-3M0 MBC or TNBC diagnosed between 2004 and 2013 and treated with definitive surgery. Chi-squared analysis was performed to determine differences between the cohorts. Kaplan-Meier curves compared overall survival (OS), and Cox regression determined patient factors associated with OS. Altogether, 55,847 patients met the inclusion criteria; 50,705 (90.8%) had TNBC and 5,142 (9.2%) had MBC. Most patients had no comorbid conditions (82%), N0 disease (71%), poorly differentiated histology (77%), received chemotherapy (87%), and received radiation therapy (60%). Amongst all patients, patients with TNBC disease were observed to have greater OS than those with MBC (5-year OS 72.0% vs 55.8%, p < 0.001). The greater observed OS for patients with TNBC persisted when controlling for stage and when comparing propensity score matched cohorts. On Cox regression, lower age, T1 status, N0 status, chemotherapy, TNBC disease, and radiation therapy (RT) were associated with improved OS. MBC had an association with poorer OS compared to TNBC, while RT and chemotherapy receipt were associated with improved OS for patients regardless of stage. Further studies are needed to corroborate the conclusions herein.

10 January 2018 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
WHWaqar M. Haque
Waqar M. Haque
VVVivek Verma
Vivek Verma
NNNilan Naik
Nilan Naik
EBE. Brian Butler
E. Brian Butler
BTBin S. Teh
Bin S. Teh

1 April 2020 in Journal of Clinical Neuroscience
Verified
Journal Article
Closed access
WHWaqar M. Haque
Waqar M. Haque
YTYvonne Thong
Yvonne Thong
VVVivek Verma
Vivek Verma
RRRobert C. Rostomily
Robert C. Rostomily
EBE. Brian Butler
E. Brian Butler
BTBin S. Teh
Bin S. Teh

1 November 2018 in Radiotherapy and Oncology
Verified
Journal Article
Closed access
WHWaqar M. Haque
Waqar M. Haque
VVVivek Verma
Vivek Verma
PPPraveen Polamraju
Praveen Polamraju
AFAndrew M Farach
Andrew M Farach
EBE. Brian Butler
E. Brian Butler
BTBin S. Teh
Bin S. Teh

31 January 2022 in Clinical Breast Cancer
Verified
Journal Article
Closed access
WHWaqar M. Haque
Waqar M. Haque
VVVivek Verma
Vivek Verma
MSMary R. Schwartz
Mary R. Schwartz
BLBora Lim
Bora Lim
NMNiva Mangalampalli
Niva Mangalampalli
BTBin S. Teh
Bin S. Teh